Bernstein Liebhard LLP is investigating whether the Board of Directors of Illumina, Inc. (“Illumina” or the “Company”) (NASDAQ:ILMN) is breaching its fiduciary duty to its shareholders in allegedly failing to embrace a premium offer by Roche and allegedly previously resisting negotiations by Roche.

As reported, Illumina shareholders would receive $44.50 in cash for each share they own. The investigation is focused on Illumina’s actions leading up to the premium offer and the offer itself.

If you are interested in discussing your rights as an Illumina shareholder and/or have information relating to the matter, please contact U. Seth Ottensoser at (877) 779-1414 or Ottensoser@bernlieb.com.

Bernstein Liebhard has pursued hundreds of securities, consumer and shareholder rights cases and recovered over $3 billion for its clients. It has been named to The National Law Journal’s “Plaintiffs’ Hot List” in each of the last nine years.

Bernstein Liebhard LLP10 East 40th StreetNew York, New York 10016(877) 779-1414www.bernlieb.com

ATTORNEY ADVERTISING. © 2012 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Mary U. Hoover. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Illumina (NASDAQ:ILMN)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more Illumina Charts.
Illumina (NASDAQ:ILMN)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more Illumina Charts.